GOVX
Price
$0.66
Change
+$0.01 (+1.54%)
Updated
Sep 24, 12:03 PM (EDT)
Capitalization
16.46M
PROK
Price
$2.78
Change
+$0.04 (+1.46%)
Updated
Sep 24, 12:23 PM (EDT)
Capitalization
369.88M
55 days until earnings call
Interact to see
Advertisement

GOVX vs PROK

Header iconGOVX vs PROK Comparison
Open Charts GOVX vs PROKBanner chart's image
GeoVax Labs
Price$0.66
Change+$0.01 (+1.54%)
Volume$557
Capitalization16.46M
ProKidney
Price$2.78
Change+$0.04 (+1.46%)
Volume$100
Capitalization369.88M
GOVX vs PROK Comparison Chart in %
Loading...
GOVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GOVX vs. PROK commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GOVX is a Hold and PROK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (GOVX: $0.65 vs. PROK: $2.74)
Brand notoriety: GOVX and PROK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GOVX: 121% vs. PROK: 43%
Market capitalization -- GOVX: $16.46M vs. PROK: $369.88M
GOVX [@Biotechnology] is valued at $16.46M. PROK’s [@Biotechnology] market capitalization is $369.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GOVX’s FA Score shows that 0 FA rating(s) are green whilePROK’s FA Score has 0 green FA rating(s).

  • GOVX’s FA Score: 0 green, 5 red.
  • PROK’s FA Score: 0 green, 5 red.
According to our system of comparison, both GOVX and PROK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GOVX’s TA Score shows that 2 TA indicator(s) are bullish while PROK’s TA Score has 5 bullish TA indicator(s).

  • GOVX’s TA Score: 2 bullish, 6 bearish.
  • PROK’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, PROK is a better buy in the short-term than GOVX.

Price Growth

GOVX (@Biotechnology) experienced а -6.90% price change this week, while PROK (@Biotechnology) price change was +4.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.31%. For the same industry, the average monthly price growth was +10.09%, and the average quarterly price growth was +53.86%.

Reported Earning Dates

PROK is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+4.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PROK($370M) has a higher market cap than GOVX($16.5M). PROK YTD gains are higher at: 62.130 vs. GOVX (-73.717). GOVX has higher annual earnings (EBITDA): -24.71M vs. PROK (-157.52M). PROK has more cash in the bank: 295M vs. GOVX (3.09M). GOVX has less debt than PROK: GOVX (195K) vs PROK (4.42M). GOVX has higher revenues than PROK: GOVX (6.14M) vs PROK (527K).
GOVXPROKGOVX / PROK
Capitalization16.5M370M4%
EBITDA-24.71M-157.52M16%
Gain YTD-73.71762.130-119%
P/E RatioN/AN/A-
Revenue6.14M527K1,166%
Total Cash3.09M295M1%
Total Debt195K4.42M4%
FUNDAMENTALS RATINGS
GOVX: Fundamental Ratings
GOVX
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GOVXPROK
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
62%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
N/A
Bullish Trend 28 days ago
73%
Declines
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 10 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
72%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
GOVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HKPD1.450.10
+7.41%
Hong Kong Pharma Digital Technology Holdings Ltd
RZLT8.520.38
+4.67%
Rezolute
BRO92.19-0.41
-0.44%
Brown & Brown
PEBK31.47-0.19
-0.60%
Peoples Bancorp of North Carolina
BRZE32.14-0.51
-1.56%
Braze

GOVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GOVX has been loosely correlated with OGEN. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if GOVX jumps, then OGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GOVX
1D Price
Change %
GOVX100%
-1.19%
OGEN - GOVX
36%
Loosely correlated
+0.75%
PROK - GOVX
31%
Poorly correlated
-2.49%
VICP - GOVX
31%
Poorly correlated
N/A
CDXS - GOVX
29%
Poorly correlated
-2.38%
AUPH - GOVX
28%
Poorly correlated
-0.54%
More

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with BGMS. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then BGMS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
-2.49%
BGMS - PROK
57%
Loosely correlated
+2.59%
MBIO - PROK
51%
Loosely correlated
-4.29%
RLYB - PROK
44%
Loosely correlated
-3.78%
RYTM - PROK
40%
Loosely correlated
-0.30%
NRIX - PROK
39%
Loosely correlated
-2.25%
More